CONTINUE TO SITE ➞

Don't miss tomorrow's medtech industry news

Let MedTech Dive's free newsletter keep you informed, straight from your inbox.

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Informa TechTarget |

BioPharma Dive
Healthcare Dive
Xtelligent Health IT

Explore our brands

An Informa TechTarget Publication

Deep Dive
Library
Events
Press Releases

FDA
M&A
Recalls
Earnings
Cybersecurity
AI
Cardiac
Diabetes
Diagnostics

What We're Reading: Page 4

Industry reads hand-picked by our editors

Mar 20, 2026

Medical Device Network
LivaNova eyes 2027 launch of neural sleep apnoea therapy after FDA approval
Fierce Healthcare
Verily banks $300M to accelerate AI road map, transitions to independent company
Reuters
Apple fends off bid for new Apple Watch import ban at US trade tribunal

Mar 19, 2026

Bloomberg
Stryker Cyberattack Delays Surgeries for Some Patients
Stat
FDA’s top infectious disease regulator to depart agency
The Wall Street Journal
Millions of Americans Are Going Uninsured Following Expiration of ACA Subsidies

Mar 18, 2026

MassDevice
Stryker CEO Kevin Lobo joins GE HealthCare board of directors
KFF Health News
Maker of Device To Treat Addiction Withdrawal Seeks Counties’ Opioid Settlement Cash
Healthcare Dive
Balancing AI innovation and risk: 5 takeaways from HIMSS26

Mar 17, 2026

MassDevice
CMR Surgical, Nvidia collab to train next-gen surgical robots
Stat
A brain-computer interface allowed people with paralysis to type with their minds
BioPharma Dive
Federal court blocks RFK Jr.’s moves to upend US vaccine policy

Mar 16, 2026

Fierce Biotech
Amplifon to build vertical hearing aid player with €2.3B GN acquisition
Medical Device Network
FDA approves J&J’s TECNIS PureSee intraocular lens
Healthcare Dive
CMS wants seniors to use AI for care navigation

Mar 13, 2026

RAPS
FDA finalizes guidance on weight-loss devices
Supply Chain Dive
CBP is working on 4-step tariff refund process
BioPharma Dive
Lilly warns GLP-1 knockoffs may be ‘dangerous,’ escalating war with compounders

Mar 12, 2026

Fierce Biotech
Newly minted MiniMed nets EU approval for 780G pump and Abbott’s Instinct CGM
Healthcare Dive
Microsoft launches dedicated health AI chatbot
The New York Times
A Third of Americans Have Cut Spending or Borrowed Money for Health Care

Previous Next

Get the free newsletter

Subscribe to MedTech Dive for top news, trends & analysis

Email:

Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Take your knowledge further with

Interested? Explore more of what has to offer.

You're all set

Thanks for signing up! Please keep an eye out for a confirmation email from [email protected] To ensure we make it into your inbox regularly, add us to your allow list, mark us as a safe sender, or add us to your address book. Check out more from

Library resources

Survey Report
Avoiding Costly Protocol Amendments: Strategies for Sponsors Custom content for Premier Research
Trendline
How AI tools are transforming the medtech space Supported by Nuance Communications
The MedTech Dive Outlook on 2026

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

BioPharma Dive
Healthcare Dive
Xtelligent Health IT

This website is owned and operated by Informa TechTarget, a global network that informs, influences and connects the world's technology buyers and sellers.

Home
- FDA
- M&A
- Recalls
- Earnings
- Cybersecurity
- AI
- Cardiac
- Diabetes
- Diagnostics
Deep Dive
Library
Events
Press Releases

Get MedTech Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.